Yi-Hui Peng

Protein Kinase Inhibitor Design by Targeting the Asp-Phe-Gly (DFG) Motif: The Role of the DFG Motif in the Design of Epidermal Growth Factor Receptor Inhibitors

Yi-Hui Peng, Hui-Yi Shiao, Chih‐Hsiang Tu et al. · Journal of Medicinal Chemistry · 2013 · 140 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Phenyl Benzenesulfonylhydrazides Exhibit Selective Indoleamine 2,3-Dioxygenase Inhibition with Potent <i>in Vivo</i> Pharmacodynamic Activity and Antitumor Efficacy

Shu‐Yu Lin, Teng‐Kuang Yeh, Ching‐Chuan Kuo et al. · Journal of Medicinal Chemistry · 2015 · 74 citations · Full text

Medicine, Oncology, Pharmacology +13

Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetochore microtubules

Jiun-Ming Wu, Chiung-Tong Chen, Mohane Selvaraj Coumar et al. · Proceedings of the National Academy of Sciences · 2013 · 55 citations · Full text

Medicine, Molecular Biology, Oncology +15

Discovery of a Furanopyrimidine-Based Epidermal Growth Factor Receptor Inhibitor (DBPR112) as a Clinical Candidate for the Treatment of Non-Small Cell Lung Cancer

Shu‐Yu Lin, Yung Chang Hsu, Yi-Hui Peng et al. · Journal of Medicinal Chemistry · 2019 · 37 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Design and Structural Analysis of Novel Pharmacophores for Potent and Selective Peroxisome Proliferator-activated Receptor γ Agonists

Chia‐Hui Lin, Yi-Hui Peng, Mohane Selvaraj Coumar et al. · Journal of Medicinal Chemistry · 2009 · 22 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16